Sale disclosed
Stephen Hoge
President
Common Stock
- Reported value
- $5.81M
- Reported price
- $144.13 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Moderna, Inc.
Last 30 daysNo qualifying insider buying. Sales: $16.38M by 2 insiders.
Showing the first 6 of 15 trades on this page.
President
Common Stock
President
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
President
Common Stock
President
Common Stock
Chief Legal Officer
Common Stock
Director
Common Stock
President
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| President | Common StockSale10b5-1 | 40,294$144.13 / share | $5.81M | Sep 14Filed Sep 16 · 2d later | SEC filing |
| President | Common StockSale10b5-1 | 40,281$146.07 / share | $5.88M | Sep 15Filed Sep 16 · 1d later | SEC filing |
| Chief Financial Officer | Common StockSale10b5-12 trades | 34,836avg $134.49 / share | $4.69M | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Chief Legal Officer | Common StockSale10b5-1 | 3,471$139.95 / share | $485.77K | Sep 1Filed Sep 3 · 2d later | SEC filing |
| Chief Executive Officer | Common StockSale10b5-14 trades | 499,246avg $57.52 / share | $28.72M | Aug 5Filed Aug 7 · 2d later | 4 filings
|
| President | Common StockSale10b5-1 | 53,336$67.60 / share | $3.61M | Jul 15Filed Jul 16 · 1d later | SEC filing |
| President | Common StockSale10b5-1 | 53,336$51.37 / share | $2.74M | Jun 15Filed Jun 17 · 2d later | SEC filing |
| Chief Legal Officer | Common StockSale10b5-1 | 3,471$50.00 / share | $173.55K | Jun 4Filed Jun 8 · 4d later | SEC filing |
| Director | Common StockSale | 9,263$46.84 / share | $433.88K | May 21Filed May 22 · 1d later | SEC filing |
| President | Common StockSale10b5-1 | 53,336$48.40 / share | $2.58M | May 15Filed May 18 · 3d later | SEC filing |
| Director | Common StockSale10b5-1 | 5,682$46.63 / share | $264.95K | May 1Filed May 4 · 3d later | SEC filing |
Moderna, Inc. - Common Stock (MRNA) · Stock
The filing reports a purchase for the member.
Maria Elvira SalazarReporting House memberModerna, Inc. - Common Stock (MRNA) · Stock
The filing reports a partial sale for the member.
Maria Elvira SalazarReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.